Accreditation & Learning Objectives

Learning Objectives

At the conclusion of this program, the participant will be able to:

• Review and analyze the latest research in infectious diseases of the skin
• Identify psoriasis with co-morbid conditions
• Assess the clinical presentations of different hair disorders
• Describe new treatment modalities for atopic dermatitis
• Understand the etiology and pathogenesis of selected skin cancers
• Examine new techniques for non-surgical fat removal
• Discuss new treatment options for acne, psoriasis and inflammatory dermatoses
• Describe the purpose of sentinel lymph node (SLN) biopsy
• Discuss the rationale for treating Actinic Keratoses
• Manage patients with dermatologic disease with medical, surgical and procedural methods and avoid complications from medical and surgical treatments
• Explain the latest advances in photodynamic therapy for patients with non-melanoma skin cancer
• Review options for soft tissue augmentation and discuss potential filler complications
• Integrate practice improvements and the latest technological advances for a successful dermatology practice
• Acquire extensive advanced experience in the use and application of various neurotoxins and dermal fillers
• Describe how current and proposed future anti-aging therapies improve skin

ACCME Accreditation

Cine-Med, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Cine-Med, Inc. designates this educational activity for a maximum of 20.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Florida Society of Dermatology and Dermatologic Surgery (Program #122200) is recognized by the American Academy of Dermatology for 20.25 AAD-Recognized Category 1 CME Credits, which may be used toward the American Academy of Dermatology's Continuing Medical Education Award.

Commercial Support

This activity is made possible, in part, through educational grants from the following commercial organizations:

• Dermik
• Galderma Laboratories
• Ranbaxy Laboratories, Inc.